Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Antimicrobial Resistance and Infection Control
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-10
DOI
10.1186/s13756-020-00863-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk factors of urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli in emergency department
- (2018) Hyeonseok Lee et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study
- (2018) Marianne Bollestad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
- (2018) Holger J. Schünemann et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli
- (2018) Yuto Haruki et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Estimating the burden of antimicrobial resistance: a systematic literature review
- (2018) Nichola R. Naylor et al. Antimicrobial Resistance and Infection Control
- Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan
- (2018) Yuko Komatsu et al. PLoS One
- An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study
- (2018) Flor Y. Ramírez-Castillo et al. Annals of Clinical Microbiology and Antimicrobials
- Impact of host-pathogen-treatment tripartite components on early mortality of patients with Escherichia coli bloodstream infection: Prospective observational study
- (2018) Eun-Jeong Yoon et al. EBioMedicine
- Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
- (2018) Alessandro Cassini et al. LANCET INFECTIOUS DISEASES
- Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital
- (2017) Hiroki Namikawa et al. INTERNAL MEDICINE
- Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital
- (2017) Arturo Artero et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease
- (2017) Jie Ma et al. MEDICINE
- Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections
- (2016) Joshua T. Thaden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs
- (2016) J.A. Maslikowska et al. JOURNAL OF HOSPITAL INFECTION
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Epidemiology and burden of multidrug-resistant bacterial infection in a developing country
- (2016) Cherry Lim et al. eLife
- Cost Attributable to Nosocomial Bacteremia. Analysis According to Microorganism and Antimicrobial Sensitivity in a University Hospital in Barcelona
- (2016) Marta Riu et al. PLoS One
- Impact of Extended-Spectrum β-Lactamase Production on Treatment Outcomes of Acute Pyelonephritis Caused by Escherichia coli in Patients without Health Care-Associated Risk Factors
- (2015) Sun Hee Park et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England
- (2015) J.K. Abernethy et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study
- (2015) B. Denis et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study
- (2015) E. Esteve-Palau et al. JOURNAL OF INFECTION
- Nosocomial bloodstream infections caused byEscherichia coliandKlebsiellapneumoniaeresistant to third-generation cephalosporins, Finland, 1999–2013: Trends, patient characteristics and mortality
- (2015) Timi Martelius et al. Infectious Diseases
- Emerging Escherichia coli O25b/ST131 Clone Predicts Treatment Failure in Urinary Tract Infections
- (2014) F. Can et al. CLINICAL INFECTIOUS DISEASES
- Economic burden of antibiotic resistance: how much do we really know?
- (2014) S. Gandra et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort
- (2014) R. Leistner et al. INFECTION
- Decreasing incidence rates of bacteremia: A 9-year population-based study
- (2014) S.L. Nielsen et al. JOURNAL OF INFECTION
- Escherichia coli Peritonitis in Peritoneal Dialysis: The Prevalence, Antibiotic Resistance and Clinical Outcomes in a South China Dialysis Center
- (2014) X. Feng et al. PERITONEAL DIALYSIS INTERNATIONAL
- High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli
- (2014) Arne Søraas et al. PLoS One
- Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia
- (2014) Stefanie Van Aken et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Costs and length of stay associated with extended-spectrum β-lactamase production in cases of Escherichia coli bloodstream infection
- (2014) Rasmus Leistner et al. Journal of Global Antimicrobial Resistance
- Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection
- (2014) Rasmus Leistner et al. Infection and Drug Resistance
- Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer
- (2013) Young Eun Ha et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children
- (2013) Nai-Chia Fan et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Risk factor of community-onset spontaneous bacterial peritonitis caused by fluoroquinolone-resistantEscherichia coliin patients with cirrhosis
- (2013) Jungok Kim et al. LIVER INTERNATIONAL
- Impact of Extended-Spectrum Beta-Lactamase on Acute Pyelonephritis Treated with Empirical Ceftriaxone
- (2013) Shinwon Lee et al. Microbial Drug Resistance
- Risk factors for bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in a Turkish hospital
- (2013) Onur Kaya et al. Journal of Infection in Developing Countries
- Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome
- (2012) Si-Hyun Kim et al. ANNALS OF HEMATOLOGY
- Empirical Use of Ciprofloxacin for Acute Uncomplicated Pyelonephritis Caused by Escherichia coli in Communities Where the Prevalence of Fluoroquinolone Resistance Is High
- (2012) Jae Hyun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population-based burden of bloodstream infections in Finland
- (2012) K. Skogberg et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes
- (2012) Joshua T. Freeman et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis
- (2012) Wouter C. Rottier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes
- (2012) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Fluoroquinolone Resistance in Uncomplicated Acute Pyelonephritis: Epidemiology and Clinical Impact
- (2012) Jaehyun Shin et al. Microbial Drug Resistance
- Patient's Origin and Lifestyle Associated with CTX-M-Producing Escherichia coli: A Case-Control-Control Study
- (2012) Marie-Hélène Nicolas-Chanoine et al. PLoS One
- Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum β-Lactamase Bloodstream Infection in Hematological Malignancies
- (2012) Patricia Cornejo-Juárez et al. PLoS One
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- GRADE guidelines: 9. Rating up the quality of evidence
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 7. Rating the quality of evidence—inconsistency
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 3. Rating the quality of evidence
- (2011) Howard Balshem et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 8. Rating the quality of evidence—indirectness
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 5. Rating the quality of evidence—publication bias
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
- (2011) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines 6. Rating the quality of evidence—imprecision
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum -Lactamase-Producing Escherichia coli Strains
- (2011) C.-I. Kang et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The clinical impact of fluoroquinolone resistance in patients with E coli bacteremia
- (2011) Bernard C. Camins et al. Journal of Hospital Medicine
- Emergence of Extended-Spectrum β-Lactamase-Producing Escherichia coli as a Cause of Community-Onset Bacteremia in South Korea: Risk Factors and Clinical Outcomes
- (2011) Sun Hee Park et al. Microbial Drug Resistance
- Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum- -Lactamase Production and Inadequate Initial Antibiotic Therapy
- (2010) M. Tumbarello et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features
- (2010) A. Courpon-Claudinon et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli
- (2010) Cheol-In Kang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins
- (2010) M. E. A. de Kraker et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical Implications, Risk Factors and Mortality Following Community-onset Bacteremia Caused by Extended-spectrum β-lactamase (ESBL) and non-ESBL Producing Escherichia coli
- (2010) Chia-Jung Hsieh et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study
- (2010) Marie-Laurence Lambert et al. LANCET INFECTIOUS DISEASES
- Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli
- (2010) Kang Cheol-In et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Epidemiology of bacteraemia in Hamad general hospital, Qatar: A one year hospital-based study
- (2010) Fahmi Yousef Khan et al. Travel Medicine and Infectious Disease
- Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coli:Risk Factors and Prognosis
- (2009) Jesús Rodríguez‐Baño et al. CLINICAL INFECTIOUS DISEASES
- Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis
- (2009) Ferran Cereto et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Bacteraemia due to extended-spectrum -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
- (2009) C. Gudiol et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome
- (2009) M. Ortega et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies
- (2009) Enrico M. Trecarichi et al. JOURNAL OF INFECTION
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis
- (2008) F. Bert et al. CLINICAL MICROBIOLOGY AND INFECTION
- Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region
- (2008) K.B. Laupland et al. CLINICAL MICROBIOLOGY AND INFECTION
- Infections due to Escherichia coli producing extended-spectrum β-lactamase among hospitalised patients: factors influencing mortality
- (2008) C. Peña et al. JOURNAL OF HOSPITAL INFECTION
- Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli
- (2008) Carlo Gagliotti et al. JOURNAL OF INFECTION
- Predictors of Mortality Among Patients With Community-Onset Infection Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli in Thailand
- (2007) Anucha Apisarnthanarak et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now